202 related articles for article (PubMed ID: 31745979)
1. The genomic landscape of nonsmall cell lung carcinoma in never smokers.
Boeckx B; Shahi RB; Smeets D; De Brakeleer S; Decoster L; Van Brussel T; Galdermans D; Vercauter P; Decoster L; Alexander P; Berchem G; Ocak S; Vuylsteke P; Deschepper K; Lambrechts M; Cappoen N; Teugels E; Lambrechts D; De Greve J
Int J Cancer; 2020 Jun; 146(11):3207-3218. PubMed ID: 31745979
[TBL] [Abstract][Full Text] [Related]
2. Whole-genome sequencing of asian lung cancers: second-hand smoke unlikely to be responsible for higher incidence of lung cancer among Asian never-smokers.
Krishnan VG; Ebert PJ; Ting JC; Lim E; Wong SS; Teo AS; Yue YG; Chua HH; Ma X; Loh GS; Lin Y; Tan JH; Yu K; Zhang S; Reinhard C; Tan DS; Peters BA; Lincoln SE; Ballinger DG; Laramie JM; Nilsen GB; Barber TD; Tan P; Hillmer AM; Ng PC
Cancer Res; 2014 Nov; 74(21):6071-81. PubMed ID: 25189529
[TBL] [Abstract][Full Text] [Related]
3. Association Between Environmental Tobacco Smoke Exposure and the Occurrence of EGFR Mutations and ALK Rearrangements in Never-smokers With Non-Small-cell Lung Cancer: Analyses From a Prospective Multinational ETS Registry.
Soo RA; Kubo A; Ando M; Kawaguchi T; Ahn MJ; Ou SI
Clin Lung Cancer; 2017 Sep; 18(5):535-542. PubMed ID: 28433570
[TBL] [Abstract][Full Text] [Related]
4. Higher TP53 somatic mutation prevalence from liquid biopsy analysis in ever smoker non-small-cell lung cancer patients.
Erdem HB; Alay MT; Özdemir Z; Çevik E; Ateş Ö; Karaçin C; Şahin İ; Doğan M; Bahsi T
Mutat Res; 2024; 828():111847. PubMed ID: 38071953
[TBL] [Abstract][Full Text] [Related]
5. Expression Profiling of Driver Genes in Female Never-smokers With Non-adenocarcinoma Non-small-cell Lung Cancer in China.
Zhao Y; Dong Y; Zhao R; Zhang B; Wang S; Zhang L; Hu M; He Q; Zhang W; Han B
Clin Lung Cancer; 2020 Sep; 21(5):e355-e362. PubMed ID: 32139332
[TBL] [Abstract][Full Text] [Related]
6. Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer.
Wen S; Dai L; Wang L; Wang W; Wu D; Wang K; He Z; Wang A; Chen H; Zhang P; Dong X; Dong YA; Wang K; Yao M; Wang M
Oncologist; 2019 Nov; 24(11):e1070-e1081. PubMed ID: 30902917
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of germline mutations in smokers and non-smokers in Brazilian non-small-cell lung cancer (NSCLC) patients.
Couto PP; Bastos-Rodrigues L; Schayek H; Melo FM; Lisboa RGC; Miranda DM; Vilhena A; Bale AE; Friedman E; De Marco L
Carcinogenesis; 2017 Oct; 38(11):1112-1118. PubMed ID: 28968711
[TBL] [Abstract][Full Text] [Related]
8. Non-small cell lung cancer in never smokers as a representative 'non-smoking-associated lung cancer': epidemiology and clinical features.
Yano T; Haro A; Shikada Y; Maruyama R; Maehara Y
Int J Clin Oncol; 2011 Aug; 16(4):287-93. PubMed ID: 21562939
[TBL] [Abstract][Full Text] [Related]
9. Genomic and evolutionary classification of lung cancer in never smokers.
Zhang T; Joubert P; Ansari-Pour N; Zhao W; Hoang PH; Lokanga R; Moye AL; Rosenbaum J; Gonzalez-Perez A; Martínez-Jiménez F; Castro A; Muscarella LA; Hofman P; Consonni D; Pesatori AC; Kebede M; Li M; Gould Rothberg BE; Peneva I; Schabath MB; Poeta ML; Costantini M; Hirsch D; Heselmeyer-Haddad K; Hutchinson A; Olanich M; Lawrence SM; Lenz P; Duggan M; Bhawsar PMS; Sang J; Kim J; Mendoza L; Saini N; Klimczak LJ; Islam SMA; Otlu B; Khandekar A; Cole N; Stewart DR; Choi J; Brown KM; Caporaso NE; Wilson SH; Pommier Y; Lan Q; Rothman N; Almeida JS; Carter H; Ried T; Kim CF; Lopez-Bigas N; Garcia-Closas M; Shi J; Bossé Y; Zhu B; Gordenin DA; Alexandrov LB; Chanock SJ; Wedge DC; Landi MT
Nat Genet; 2021 Sep; 53(9):1348-1359. PubMed ID: 34493867
[TBL] [Abstract][Full Text] [Related]
10. Genomic Profiling of Lung Adenocarcinoma in Never-Smokers.
Devarakonda S; Li Y; Martins Rodrigues F; Sankararaman S; Kadara H; Goparaju C; Lanc I; Pepin K; Waqar SN; Morgensztern D; Ward J; Masood A; Fulton R; Fulton L; Gillette MA; Satpathy S; Carr SA; Wistuba I; Pass H; Wilson RK; Ding L; Govindan R
J Clin Oncol; 2021 Nov; 39(33):3747-3758. PubMed ID: 34591593
[TBL] [Abstract][Full Text] [Related]
11. Whole genome copy number analyses reveal a highly aberrant genome in TP53 mutant lung adenocarcinoma tumors.
Bjaanæs MM; Nilsen G; Halvorsen AR; Russnes HG; Solberg S; Jørgensen L; Brustugun OT; Lingjærde OC; Helland Å
BMC Cancer; 2021 Oct; 21(1):1089. PubMed ID: 34625038
[TBL] [Abstract][Full Text] [Related]
12. Lungs don't forget: Comparison of the KRAS and EGFR mutation profile and survival of collegiate smokers and never smokers with advanced lung cancers.
Varghese AM; Sima CS; Chaft JE; Johnson ML; Riely GJ; Ladanyi M; Kris MG
J Thorac Oncol; 2013 Jan; 8(1):123-5. PubMed ID: 23242442
[TBL] [Abstract][Full Text] [Related]
13. EGFR and erbB2 mutation status in Japanese lung cancer patients.
Sasaki H; Shimizu S; Endo K; Takada M; Kawahara M; Tanaka H; Matsumura A; Iuchi K; Haneda H; Suzuki E; Kobayashi Y; Yano M; Fujii Y
Int J Cancer; 2006 Jan; 118(1):180-4. PubMed ID: 16003726
[TBL] [Abstract][Full Text] [Related]
14. Real World Characterization of Advanced Non-Small Cell Lung Cancer in Never Smokers by Actionable Mutation Status.
Kerrigan K; Wang X; Haaland B; Adamson B; Patel S; Puri S; Akerley W
Clin Lung Cancer; 2021 Jul; 22(4):260-267.e2. PubMed ID: 33678584
[TBL] [Abstract][Full Text] [Related]
15. Patterns of EGFR, HER2, TP53, and KRAS mutations of p14arf expression in non-small cell lung cancers in relation to smoking history.
Mounawar M; Mukeria A; Le Calvez F; Hung RJ; Renard H; Cortot A; Bollart C; Zaridze D; Brennan P; Boffetta P; Brambilla E; Hainaut P
Cancer Res; 2007 Jun; 67(12):5667-72. PubMed ID: 17575133
[TBL] [Abstract][Full Text] [Related]
16. Mutational landscape and characteristics of ERBB2 in non-small cell lung cancer.
Wei XW; Gao X; Zhang XC; Yang JJ; Chen ZH; Wu YL; Zhou Q
Thorac Cancer; 2020 Jun; 11(6):1512-1521. PubMed ID: 32291971
[TBL] [Abstract][Full Text] [Related]
17. The prognostic effect of single and multiple cancer-related somatic mutations in resected non-small-cell lung cancer.
Jao K; Tomasini P; Kamel-Reid S; Korpanty GJ; Mascaux C; Sakashita S; Labbé C; Leighl NB; Liu G; Feld R; Bradbury PA; Hwang DM; Pintilie M; Tsao MS; Shepherd FA
Lung Cancer; 2018 Sep; 123():22-29. PubMed ID: 30089591
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of genomic alterations of lung adenocarcinoma in young never-smokers.
Luo W; Tian P; Wang Y; Xu H; Chen L; Tang C; Shu Y; Zhang S; Wang Z; Zhang J; Zhang L; Jiang L; Liu L; Che G; Guo C; Zhang H; Wang J; Li W
Int J Cancer; 2018 Oct; 143(7):1696-1705. PubMed ID: 29667179
[TBL] [Abstract][Full Text] [Related]
19. EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.
Bae NC; Chae MH; Lee MH; Kim KM; Lee EB; Kim CH; Park TI; Han SB; Jheon S; Jung TH; Park JY
Cancer Genet Cytogenet; 2007 Mar; 173(2):107-13. PubMed ID: 17321325
[TBL] [Abstract][Full Text] [Related]
20. Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement.
Kim HR; Shim HS; Chung JH; Lee YJ; Hong YK; Rha SY; Kim SH; Ha SJ; Kim SK; Chung KY; Soo R; Kim JH; Cho BC
Cancer; 2012 Feb; 118(3):729-39. PubMed ID: 21720997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
